Jan 06, 2022 7:00am EST Sutro Biopharma to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
Jan 05, 2022 4:30pm EST Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
Dec 27, 2021 7:00am EST Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China
Dec 27, 2021 7:00am EST Sutro Biopharma Announces Company KOL Virtual Event to Provide Interim Dose Expansion Data for Antibody-Drug Conjugate Program STRO-002 for Treatment of Advanced Ovarian Cancer
Dec 13, 2021 7:00am EST Fred Hutchinson Cancer Research Center, in Partnership with Sutro Biopharma, to Present at ASH 2021
Nov 10, 2021 7:00am EST Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
Oct 12, 2021 7:00am EDT Sutro Biopharma and BioNova Pharmaceuticals Enter into Collaboration for STRO-001 in Greater China
